Jeff Ubben founded ValueAct Capital, one of the best-known activist investors on Wall Street. When he left it in 2020 he declared that “finance is, like, done”.
Yet he has now returned to activism in a big way. Last week he disclosed a €400mn stake in Germany’s Bayer and called for a new chief executive from outside the company.
It is the biggest investment to date for Inclusive Capital Partners, the fund Ubben set up on his exit from ValueAct with an aim of pushing companies to make environmental and social improvements to drive returns higher. The results at Bayer will test his thesis.
您已阅读11%（595字），剩余89%（5035字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。